Evidence map›Paper›PMID 27933202›Full record

ArticleBMJ open gastroenterology2016

Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia.

Yoona A Kim, Jacqueline Estevez, An Le, Dennis Israelski, Oidov Baatarkhuu, Tserenchimed Sarantuya, Sonom Narantsetseg, Pagbajabyn Nymadawa, Richard H Le, Man-Fung Yuen and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 6 countries.

Yoona A KimDivision of Gastroenterology and Hepatology , Stanford University , Stanford, California , USA.
Jacqueline EstevezDivision of Gastroenterology and Hepatology , Stanford University , Stanford, California , USA.
An LeDivision of Gastroenterology and Hepatology , Stanford University , Stanford, California , USA.
Dennis IsraelskiCenter for Innovation in Global Health, Stanford University, Stanford, California, USA; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA.
Oidov BaatarkhuuDepartment of Infectious Diseases , Mongolian National University of Medical Sciences , Ulaanbaatar , Mongolia.
Tserenchimed SarantuyaDepartment of Internal Medicine , United Family Intermed Hospital , Ulaanbaatar , Mongolia.
Sonom NarantsetsegShastin Memorial Third National General Hospital of Mongolia , Ulaanbaatar , Mongolia.
Pagbajabyn NymadawaPublic Health Branch , Mongolian Academy of Medical Sciences , Ulaanbaatar , Mongolia.
Richard H LeDivision of Gastroenterology and Hepatology , Stanford University , Stanford, California , USA.
Man-Fung YuenDivision of Gastroenterology and Hepatology , Queen Mary Hospital, The University of Hong Kong , Hong Kong , Hong Kong.
Geoffrey DusheikoKings College Hospital and University College London School of Medicine , London , UK.
Mario RizzettoDepartment of Gastroenterology , University of Turin , Turin , Italy.
Mindie H NguyenDivision of Gastroenterology and Hepatology, Stanford University, Stanford, California, USA; Center for Innovation in Global Health, Stanford University, Stanford, California, USA.
Stanford University · USCenter for Innovation · USMongolian Academy of Sciences · MNMongolian National University · MNMongolian National University of Medical Sciences · MNUniversity College London · GBUniversity of Hong Kong · HKUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccording to Globocan, Mongolia has the highest worldwide hepatocellular carcinoma (HCC) incidence (78.1/100 000, 3.5× higher than China). AIMS AND

methodsWe conducted an anonymous survey of physicians from major provinces who attended an educational liver symposium, analysing their demography, practice, knowledge, perceptions and proposed solutions. Multivariate logistic regression was used to estimate OR relating demography and practice factors with higher provider knowledge and improvement.

resultsOf the 121 attendees, 44-95 (36-79%) responded to each question. Most were female (87%), young (79% age <50), subspecialists (81%), university-affiliated (74%), and practised in urban areas (61%). The mean pretest and post-test scores per physician were 60.4±20.4 and 65.6±21.3, with no observed significant predictors for baseline knowledge or improvement. Most (>80%) noted that <50% of patients who need hepatitis or HCC screening receive it. The main perceived barriers to screening were inability to pay for tests, lack of guidelines and poor patient awareness. Hepatitis treatment rates were low; 83% treated hepatitis C virus in <10 patients in the past year, and 86% treated hepatitis B virus in <10 patients/month. Treatment barriers were multifactorial, with cost as a principal barrier. Proposed solutions were universal screening policies (46%), removal of financial barriers (28%) and provider education (20%).

conclusionsPhysicians from major regions of Mongolia noted low screening for viral hepatitis, even lower treatment rates, financial barriers and the need for increased educational efforts. We advocate broad-based medical education tailored to local needs and based on needs assessment and outcome measurements.

Indexed as

CHRONIC VIRAL HEPATITISHEPATITIS BHEPATOCELLULAR CARCINOMA

Identifiers

PMID27933202
PMCPMC5128837
OpenAlexW2551658661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.